Their sales uptick least in 17 quarters
The initial public offer of Sudeep Pharma Ltd received 5.09 times subscription on the second day of bidding on Monday. The IPO received bids for 5,37,83,650 shares against 1,05,64,926 shares on offer, according to NSE data. The category for non-institutional investors fetched 12 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 4.96 times. The Qualified Institutional Buyers (QIBs) portion received 13 per cent subscription. Sudeep Pharma on Thursday said it has mobilised Rs 268.5 crore from anchor investors. The Rs 895 crore initial public offering (IPO) will conclude on Tuesday. The price band has been fixed at Rs 563-593 per equity share. The IPO has a fresh issue of equity shares worth Rs 95 crore and an offer-for-sale of nearly 1.35 crore equity shares, aggregating to Rs 800 crore, by the promoters. Proceeds from the fresh issue to the tune of Rs 75.81 crore will be used for capital expenditure towards the procurement of machinery for it
Two-thirds of global indices race to lifetime highs - the widest run in 18 years - while Nifty stumbles at the line
Renovations easing and wedding-heavy months ahead may help close the gap left by a soft start
Despite demand challenges and export headwinds, analysts say Bharat Forge's diversified revenue base, strong defence order pipeline
A smarter load mix and tightened cost base give it a cleaner, more controlled run than its biggest rival
Pandey says new disclosure rules for Sebi staff and board aim to boost trust
Fintech firm Pine Labs made a strong market debut with a 14 per cent rise over its issue price, even as subscription levels were modest
They accounted for 39.1 per cent of the premium paid to trade equity options in September 2025, shows the National Stock Exchange (NSE) data on category-wise turnover,
A Sebi committee led by former vigilance chief Pratyush Sinha has proposed mandatory asset disclosures, tighter investment rules, and an ethics oversight system for top officials to prevent conflicts
The grooming brand raised Rs 136 crore from Sixth Sense Ventures, founder Shantanu Deshpande, Rahul Dravid, and others as it plans an IPO after achieving profitability and Rs 550 crore run-rate
Over ₹1.5 trillion raised, with major listings still queued down the track
Foreign investors take a breather amid trade uncertainties, while IPO activity stays strong with four listings this week
The entire cashflow impact will be visible in H2FY26 though management is guiding for 70-80 per cent loss recovery in insurance
Cofounders say they will not entertain investors who them to increase course prices for revenue
The Great Defensive Slump: 2025 turned FMCG, IT, and pharma into market laggards. Yet with earnings stable and valuations cooling, their next move could surprise
On track for continued outperformance in FY26 with strategic launches, premiumisation
October inflows estimated at ₹7,800 crore; silver ETF inflows also buoyant
October's ADR hit 1.08 - its highest since June - as easing outflows let rally catch new air
The Nifty struggles to hold above 26,000 amid profit-taking, while Lenskart's ambitious IPO valuation divides investors. Grey market signals modest optimism for Groww and Studds